Although age did not correlate with frequency of KRAS mutations in our cohort (Supplementary Data 25), it would be intriguing to determine whether these factors are also relevant in the contexts of adenomyosis and endometriosis, a question demanding future studies using a larger patient cohort. This evidence concerns the gene KRAS and adenomyosis.